NewAmsterdam Pharma Company
NAMS
#4115
Rank
HK$17.32 B
Marketcap
HK$187.52
Share price
6.54%
Change (1 day)
146.87%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2024 (TTM): -HK$1.44 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are HK$14.02 Million. In 2023 the company made an earning of -HK$1.38 Billion a decrease over its 2022 earnings that were of -HK$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$1.44 Billion4.52%
2023 -HK$1.38 Billion628.66%
2022-HK$0.19 Billion-48.69%
2021-HK$0.37 Billion444.1%
2020-HK$67.62 Million